Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Login Sign up free
Home Stock ScreenerScreener ETF ScreenerETF Maps Charts News Groups Insider Futures Forex Crypto Watchlist Portfolio Calendar
Pricing

New Upgrade:   Dedicated Screeners for Stocks & ETFs

Learn more
Market News Market Pulse Stocks News ETF News Crypto News

Immunocore Holdings plc

Contributing Author

Recent Articles by Immunocore Holdings plc

Oct-29
Immunocore will present Phase 1 data for brenetafusp plus KIMMTRAK (tebentafusp-tebn) in metastatic uveal melanoma, during a late-breaking oral session at the 2026 SITC meeting IMCR GlobeNewswire
Oct-15
Immunocore announces first patient dosed in the Phase 1 trial of IMC-S118AI - its first tissue-specific autoimmune candidate - for patients with type 1 diabetes IMCR GlobeNewswire
Sep-14
Immunocore announces achievement of target enrollment in registrational TEBE-AM trial with KIMMTRAK (tebentafusp) in previously treated advanced melanoma IMCR GlobeNewswire
Sep-01
Immunocore to present at upcoming investor conferences IMCR GlobeNewswire
Aug-06
Immunocore reports second quarter financial results and provides a business update IMCR GlobeNewswire
Jul-30
Immunocore to report second quarter 2026 financial results and host call on August 6, 2026 IMCR GlobeNewswire
May-31
Immunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma IMCR GlobeNewswire
May-06
Immunocore reports first quarter financial results and provides a business update IMCR +6.55% GlobeNewswire
Apr-19
KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma IMCR GlobeNewswire
Apr-06
Immunocore to present at the 25th Annual Needham Virtual Healthcare Conference IMCR GlobeNewswire
Mar-17
Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meeting IMCR GlobeNewswire
Mar-03
Immunocore to present at upcoming investor conferences IMCR GlobeNewswire
Feb-25
Immunocore reports fourth quarter and full year 2025 financial results and provides a business update IMCR GlobeNewswire
Feb-18
Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025 IMCR GlobeNewswire
Jan-30
Immunocore announces R&D leadership evolution IMCR GlobeNewswire
Jan-09
Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference IMCR GlobeNewswire
Nov-10
Immunocore to present at upcoming investor conferences IMCR GlobeNewswire
Nov-07
Immunocore presents Phase 1 data for hepatitis B candidate at AASLD's The Liver Meeting IMCR +6.03% GlobeNewswire
Nov-06
Immunocore reports third quarter financial results and provides a business update IMCR GlobeNewswire
Sep-04
Immunocore to present at upcoming investor conferences IMCR GlobeNewswire
Aug-07
Immunocore reports second quarter financial results and provides a business update IMCR GlobeNewswire
Jul-31
Immunocore to report second quarter 2025 financial results and host call on August 7, 2025 IMCR GlobeNewswire
Jun-02
Immunocore to present at the 2025 Jefferies Global Healthcare Conference IMCR +5.60% GlobeNewswire
May-07
Immunocore reports first quarter financial results and provides a business update IMCR +6.63% GlobeNewswire
Affiliate • Advertise • APIs • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)